Futura Medical PLC
LSE:FUM

Watchlist Manager
Futura Medical PLC Logo
Futura Medical PLC
LSE:FUM
Watchlist
Price: 32 GBX 0.16%
Market Cap: 97.2m GBX
Have any thoughts about
Futura Medical PLC?
Write Note

Futura Medical PLC
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Futura Medical PLC
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Futura Medical PLC
LSE:FUM
Other Current Liabilities
ÂŁ644.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Other Current Liabilities
ÂŁ2.7B
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
2%
AstraZeneca PLC
LSE:AZN
Other Current Liabilities
$2.7B
CAGR 3-Years
20%
CAGR 5-Years
12%
CAGR 10-Years
-2%
Verona Pharma PLC
NASDAQ:VRNA
Other Current Liabilities
$2m
CAGR 3-Years
50%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Other Current Liabilities
$624m
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
12%
Dechra Pharmaceuticals PLC
LSE:DPH
Other Current Liabilities
ÂŁ15.6m
CAGR 3-Years
-23%
CAGR 5-Years
1%
CAGR 10-Years
-13%
No Stocks Found

Futura Medical PLC
Glance View

Market Cap
95.7m GBX
Industry
Pharmaceuticals

Futura Medical Plc is a pharmaceutical group that develops products for both the prescription and consumer healthcare markets. The company is headquartered in Guildford, Surrey and currently employs 13 full-time employees. The company went IPO on 2006-07-10. The firm is focused on developing a portfolio of products based on its transdermal DermaSys technology. Its patented transdermal DermaSys technology provides rapid and targeted local delivery of medical treatments via the skin. The firm is engaged in developing a portfolio of products for therapeutic areas, such as sexual health, including erectile dysfunction, and pain relief. The firm's products include MED3000 and TPR100. The firm's lead product, MED3000, is a topical gel formulation treatment for erectile dysfunction (ED) through an evaporative mode of action. The firm has conducted a Phase III study using MED3000 in ED. TPR100 is a topical non-steroidal anti-inflammatory for the pain and inflammation associated with sprains, strains and bruises and soft tissue rheumatism.

FUM Intrinsic Value
15.77 GBX
Overvaluation 51%
Intrinsic Value
Price

See Also

What is Futura Medical PLC's Other Current Liabilities?
Other Current Liabilities
644.1k GBP

Based on the financial report for Jun 30, 2024, Futura Medical PLC's Other Current Liabilities amounts to 644.1k GBP.

What is Futura Medical PLC's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 1Y
0%

Over the last year, the Other Current Liabilities growth was 0%.

Back to Top